Stock- Based Awards and Stock-Based Employee Compensation Expense | 3. Stock- Based Awards and Stock-Based Employee Compensation Expense Our stock-based awards include (i) stock options, (ii) restricted stock awards, some of which are subject to time-based vesting (“Restricted Stock”) and some of which are subject to performance-based vesting (“Performance Stock”), and (iii) restricted stock units, some of which are subject to time-based vesting (“RSUs”) and some of which are subject to performance-based vesting (“Performance RSUs”). As of September 30, 2017, the Company had 1,059,290 stock options outstanding, 1,144,481 non-vested Restricted Stock awards; 193,110 non-vested Performance Stock awards; 129,420 non-vested RSUs; 60,663 non-vested Performance RSUs and 1,152,394 shares of common stock available for grant. Stock Option Activity The following is a summary of all stock option transactions during the three months ended September 30, 2017: Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Yrs) Outstanding at June 30, 2017 1,075,486 $ 3.19 Granted at market price — — Cancelled or expired (2,000 ) 1.85 Exercised (14,196 ) 4.87 Outstanding at September 30, 2017 1,059,290 $ 3.17 5.46 Options exercisable at September 30, 2017 843,914 $ 3.00 4.65 At September 30, 2017, 1,028,540 stock options outstanding and 828,540 stock options exercisable had an exercise price lower than the market price of the Company’s common stock on that date. The aggregate intrinsic value of these stock options were $1.8 million and $1.6 million, respectively. The Company did not record an excess tax benefit for the three and nine month periods ended September 30, 2017, related to the exercise of stock options. The Company recorded a $37 thousand excess tax benefit in the three month period ended September 30, 2016, related to the exercise of 74,873 stock options. The Company recorded a $39 thousand excess tax benefit for the nine month period ended September 30, 2016, related to the exercise of 94,685 stock options. Restricted Stock Activity The following is a summary of Restricted Stock activity during the three months ended September 30, 2017: Restricted Shares Weighted Average Fair Value Non-vested restricted stock at June 30, 2017 1,157,303 $ 4.57 Granted at market price 15,000 5.26 Vested (27,822 ) 4.04 Cancelled — — Non-vested restricted stock at September 30, 2017 1,144,481 $ 4.60 The Company did not record an excess tax benefit for the three and nine month periods ended September 30, 2017, related to Restricted Stock awards that vested. The Company recorded a $35 thousand excess tax benefit for the three month period ended September 30, 2016, related to 91,740 Restricted Stock awards that vested. The Company recorded a $67 thousand excess tax benefit for the nine month period ended September 30, 2016, related to 263,979 Restricted Stock awards that vested. Restricted Stock Unit Activity The following is a summary of all RSU activity during the three months ended September 30, 2017: Restricted Stock Units Weighted Average Fair Value Non-vested restricted stock units at June 30, 2017 129,420 $ 4.39 Granted at market price — — Vested — — Cancelled — — Non-vested restricted stock units at September 30, 2017 129,420 $ 4.39 The Company did not record an excess tax benefit for the three and nine month periods ended September 30, 2017, related to RSUs that vested. The Company recorded a $3 thousand excess tax benefit for the three month period ended September 30, 2016, related to 48,250 RSU’s that vested. The Company recorded an $8 thousand excess tax benefit for the nine month period ended September 30, 2016, related to 179,914 RSUs that vested. Performance RSU Activity The following is a summary of all Performance RSU activity during the three months ended September 30, 2017: Performance RSUs Weighted Average Fair Value Non-vested performance RSUs at June 30, 2017 60,663 $ 4.02 Granted at market price — — Vested — — Forfeited — — Non-vested performance RSUs at September 30, 2017 60,663 $ 4.02 The Company did not record an excess tax benefit for the three and nine month periods ended September 30, 2017. The Company recorded a $3 thousand excess tax benefit for the three month period ended September 30, 2016, related to 20,000 Performance RSU’s that vested. The Company recorded a $15 thousand excess tax benefit for the nine month period ended September 30, 2016, related to 97,428 Performance RSUs that vested. Performance Stock Activity The following is a summary of all Performance Stock activity during the three months ended September 30, 2017: Performance Stock Weighted Average Fair Value Non-vested performance stock at June 30, 2017 193,110 $ 4.39 Granted at market price — — Vested — — Forfeited — — Non-vested performance stock at September 30, 2017 193,110 $ 4.39 The Company did not record an excess tax benefit for the three and nine month periods ended September 30, 2017.The Company recorded a $5 thousand excess tax benefit in the three and nine month periods ended September 30, 2016, related to 20,000 Performance Stock awards that vested. The weighted average grant-date fair value of awards of Restricted Stock, RSUs, Performance RSUs and Performance Stock is based on the quoted market price of the Company’s common stock on the date of grant. Stock-Based Compensation Expense For the three and nine month periods ended September 30, 2017, the total stock-based employee compensation expense resulting from stock options, Restricted Stock, RSUs, Performance RSUs and Performance Stock was recorded to the following line items of the Company’s condensed consolidated statements of income: (In thousands) Three Months Ended September 30, 2017 Nine Months Ended September 30, 2017 Cost of revenues $ 78 $ 226 Research and development 99 276 Selling, general and administrative 567 1,521 Stock-based compensation expense $ 744 $ 2,023 A deferred tax asset totaling $603 thousand and $429 thousand, resulting from stock-based compensation expense associated with awards relating to the Company’s U.S. operations, was recorded for the nine month periods ended September 30, 2017 and 2016, respectively. As of September 30, 2017, there was $5.5 million of total unrecognized stock-based compensation expense related to non-vested stock-based compensation awards granted under the incentive plans. This expense is expected to be recognized over a weighted average period of 1.60 years. For additional information regarding the Company’s Equity Awards and Stock-based Employee Compensation, see Note 3 to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. |